What does the evidence say about Kefir Gut Microbiome Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Kefir Gut Microbiome Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - The risk of bias was assessed using Cochrane risk-of-bias tool and Risk of bias of non-randomized trials. [Hamsho M (2026); evidence level 1] - Kefir-specific bacterial species and strains were found in participants fecal samples suggesting colonization properties. [Hamsho M (2026); evidence level 1] - Kefir consumption was associated with modest and heterogenous changes in gut microbiota composition. [Hamsho M (2026); evidence level 1] - Kefir is a fermented dairy product containing live and active microbial culture, including lactic acid bacteria and yeast. [Hamsho M (2026); evidence level 1] - There is strong evidence of a correlation linking gut dysbiosis with reduced microbial diversity and a disruption in the balance of microbial communities, and inflammatory and metabolic disorders, including obesity and type 2 diabetes mellitus (T2DM) [,,]. [Alhaj Omar A. (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.